Can Fite Bio (CANF) Q3 2022 Earnings Report

4 Followers

IL:CANF Q3 2022 EPS Results

Actual EPS-2857.52

Consensus EPS-2767.71

Beat/MissMissed by -89.81

One Year Ago EPS-5842.99

Actual Revenue69.41M

Expected Revenue92.27M

Beat/MissMissed by -22.86M

YoY Revenue Growth-14.49%

QuarterQ3 2022

Date11/25/2022

TimeBefore Open

Conference CallFriday, November 25, 2022

IL:CANF Upcoming Earnings

Can Fite Bio's next earnings date is estimated for April 1, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Apr 01, 2027	2026 (Q4)	-123.02 / -	-918.06	―
Sep 08, 2026	2026 (Q2)	-50.75 / -190.69	-430.274	55.68% (+239.59)
Mar 26, 2026	2025 (Q4)	-21.53 / -918.06	-583.745	-57.27% (-334.32)
Nov 21, 2025	2025 (Q3)	-430.27 / -84.89	―	―
Aug 28, 2025	2025 (Q2)	-338.01 / -430.27	-1014.018	57.57% (+583.74)
May 22, 2025	2025 (Q1)	- / -	―	―
Apr 14, 2025	2024 (Q4)	-307.25 / -430.27	-1075.223	59.98% (+644.95)
Nov 29, 2024	2024 (Q3)	-0.31 / -0.31	-0.308	0.00% (0.00)
Aug 29, 2024	2024 (Q2)	-338.01 / -1014.02	-1075.223	5.69% (+61.20)
May 30, 2024	2024 (Q1)	-0.31 / -0.31	0	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed